Friday, September 2, 2016

BRIEF-Versartis presents data for Somavaratan

* Versartis presents efficacy, safety, metabolic and

adherence data for somavaratan in oral session at international

congress of endocrinology

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)